News & Updates
Showing Paediatrics articles
Showing
Show Multimedia Only

Lenacapavir serves its PURPOSE in young individuals
11 Aug 2025
byAudrey Abella
Twice-yearly subcutaneous (SC) lenacapavir demonstrates high efficacy, favourable safety, and consistent pharmacokinetics (PK) as pre-exposure prophylaxis (PrEP) for HIV-negative youth (aged 16–25 years) in an analysis of the phase III PURPOSE 1 (P1) and PURPOSE 2 (P2) trials.
11 Aug 2025

Which factors predict cognitive outcomes in children with autism?
01 Aug 2025
byStephen Padilla
A recent Singapore study has identified several factors, such as Autism Diagnostic Observation Schedule (ADOS) score and race, that can predict intellectual impairment among children with autism spectrum disorder (ASD).
01 Aug 2025






